RPRX
Royalty Pharma plc
Stock
$57.16−0.47 (−0.82%)Close Oct 2, 2026
- Net income, 2025
- $771M
- YoY, 2025
- −10.2%
- 5-year CAGR
- −4.6%
Net income
Net income by fiscal year
| Period | Net income | YoY |
|---|---|---|
| 2025 | $771M | −10.2% |
| 2024 | $859M | −24.3% |
| 2023 | $1.1B | +2,549.5% |
| 2022 | $43M | −93.1% |
| 2021 | $620M | −36.4% |
| 2020 | $975M | −58.5% |
| 2019 | $2.3B | +70.5% |
| 2018 | $1.4B | — |